Lipid metabolism-MAFLD crosstalk: mechanisms and therapy - Top-Institutions - MDSpire

Lipid metabolism-MAFLD crosstalk: mechanisms and therapy

  • By

  • Bojia Li

  • Shengai Piao

  • Yin Fu

  • Qiang Fu

  • Peiyao Qin

  • Weitai Kong

  • Yidi Ma

  • Zhe Zhang

  • Xue Fang

  • Xiaoyang Hu

  • March 18, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Metabolic Diseases
    • Lipid Metabolism

  • #2

    University of California, San Diego (UCSD) - NAFLD Research Center
    University of California, San Diego (UCSD) - NAFLD Research Center

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Metabolic Liver Disease
    • Clinical Trials

  • #3

    Mount Sinai Health System - Icahn School of Medicine
    Mount Sinai Health System - Icahn School of Medicine

    New York, NY

    Key Differentiators

    • Hepatology
    • Metabolic Disorders
    • Lipidomics

  • #4

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Hepatology
    • Metabolic Research
    • Lipid Metabolism

  • #5

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - NIH
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - NIH

    Bethesda, MD

    Key Differentiators

    • Metabolic Diseases
    • Hepatology
    • Translational Research

Original Source(s)

Lipid metabolism-MAFLD crosstalk: mechanisms and therapy

  • by Bojia Li, Shengai Piao, Yin Fu, Qiang Fu, Peiyao Qin, Weitai Kong, Yidi Ma, Zhe Zhang, Xue Fang, Xiaoyang Hu

  • March 18, 2026

Related Content

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

Metabolomic signatures mediate the association between physical frailty and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study

Impact of Early Weight Gain on Alanine Aminotransferase Levels at Age 8: Insights from the Japan Environment and Children’s Study